COPPADIS-2015 aimed to assess the progression and impact of Parkinson's Disease (PD) in Spain. Beginning in 2015, the study involved over 1,100 individuals, of which 694 were PD patients, 273 were caregivers, and 207 were control participants. These individuals were recruited between 2016 and 2017, and participants with PD ranged from 30 to 75 years old. Participants were followed up annually for 5 years, with the follow-up concluded at the end of 2023.
Study design
Cohort - clinical
Number of participants at first data collection
694 (participants with Parkinson's disease)
207 (controls)
273 (caregivers of participants with Parkinson's disease)
Age at first data collection
30 - 75 years (participants with Parkinson's disease)
Varied (controls)
Varied (caregivers of participants with Parkinson's disease)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2015
Primary Institutions
Alcorcón Hospital Foundation (Fundación Hospital de Alcorcón) (Healthcare/Medical, Spain)
Architect Marcide Hospital (Arquitecto Marcide Hospital) (Healthcare/Medical, Spain)
Arnau de Vilanova Hospital (Hospital Arnau de Vilanova) (Healthcare/Medical, Spain)
Burgos University Hospital Complex (Complejo Asistencial Universitario de Burgos) (Healthcare/Medical, Spain)
Central Hospital of Asturias (Hospital Central de Asturias) (Healthcare/Medical, Spain)
Profile paper DOI
Funders
AbbVie (Industry, United States of America)
Acebre (Industry, Spain)
City Council of Coruña (Ayuntamiento de A Coruña) (Government, Spain)
Climanosa (Industry, Spain)
Construdeco Norte (Industry, Spain)
Ongoing?
No
Data types collected


Engagement
Keywords